Safety and reactogenicity of the recombinant zoster vaccine after allogeneic hematopoietic cell transplantationEmily Baumrin, Nicolas C. Issa, Natalie Izaguirre et al.|Blood Advances|2021Cited by 38
Activity of mRNA COVID-19 vaccines in patients with lymphoid malignanciesJennifer L. Crombie, Nicolas C. Issa, Natalie Izaguirre et al.|Blood Advances|2021Cited by 24
Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Immunogenicity and ReactogenicityAmy C Sherman, Lindsey R. Baden, Michaël Desjardins et al.|Clinical Infectious Diseases|2021Cited by 24
586. Immunogenicity of COVID-19 mRNA Vaccines in Patients with Lymphoid MalignanciesNatalie Izaguirre, Lindsey R. Baden, Amy C Sherman et al.|Open Forum Infectious Diseases|2021Cited by 1